Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Ionis Out-Licenses Second Candidate to AstraZeneca, Earns $30M

37m zacks
Ionis Pharmaceuticals, Inc. (IONS - Free Report) announced that it has out-licensed IONIS-AZ5-2.5Rx, a Generation 2.5 antisense drug, to AstraZeneca (AZN - Free Report) . The candidate will be developed to treat a genetically associated form of kidney disease. (122-0)

AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion

2018-02-19 zacks
AstraZeneca (AZN - Free Report) announced that the FDA has approved a second indication for its PD-L1 inhibitor, Imfinzi. It is now approved for unresectable Stage III non-small cell lung cancer (“NSCLC”). The drug is meant for patients whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. (74-0)

AstraZeneca Scores FDA First, Time To Capitalize Before Competitors Roll In

2018-02-19 seekingalpha
AstraZeneca obtains first FDA approval for Imfinzi for stage 3 lung cancer patients with unresectable tumors and those who have not progressed after chemoradiation therapy. (39-0)

BioSci Rounds Report For Feb. 16, 2018

2018-02-18 seekingalpha
FDA approved durvalumab (Imfinzi) for the treatment of stage 3 non-small cell lung cancer (without metastasis and are unresectable). (94-0)

Ironwood (IRWD) Beats Estimates in Q4 Earnings, Stock Up

2018-02-16 zacks
Ironwood Pharmaceuticals, Inc. (IRWD - Free Report) reported fourth-quarter 2017 adjusted loss of 14 cents per share, narrower than the Zacks Consensus Estimate of a loss of 21 cents. However, the company had reported adjusted loss of 12 cents in the year-ago period. (127-0)

Your Daily Pharma Scoop: Shire Looks Attractive, Omeros Data, Axovant Restructuring

2018-02-15 seekingalpha
Today we will discuss Shire Plc (SHPG), which is continuing with its bad run. Year to date, SHPG shares have fallen nearly 14%. Of course, the sell-off this year can be attributed to the bearish sentiment in general in the market. But Shire also had a disappointing 2017 even as the NBI posted gains of more than 21%. (210-2)

Amgen As A Source Of Funds

2018-02-12 seekingalpha
Once a biotech leader, AMGN has been unable to deliver a blockbuster new product launch since Prolia in 2010. (184-0)

Understanding GlaxoSmithKline's Trelegy Ellipta

2018-02-08 seekingalpha
Sometimes security research is really like an abstract painting. If you go beyond taking for granted nicely spun company communications, it's easy to get lost. (42-0)

Bristol-Myers Squibb Makes Enormous Advance In First-Line Lung Cancer

2018-02-06 seekingalpha
Bristol-Myers Squibb combo of Opdivo and Yervoy improved progression-free survival for advanced lung cancer patients with tumor mutation burden who have not been previously treated. (38-0)

AstraZeneca's (AZN) CEO Pascal Soriot on Q4 2017 Results - Earnings Call Transcript

2018-02-05 seekingalpha
All right, good afternoon, everybody. Good morning to those of you who are joining us by telephone. Welcome to our full year results presentation, our conference call and webcast to investor and analyst. We’re here in London and we've people with us here in the room, on the phone and on the webcast. As usual, the presentation is available for those of you want to access it online at astrazeneca.com for you to download it. (54-0)

Foreign Stock Roundup: RDS.A & AZN Impress, NVO & BABA Disappoint

2018-02-05 zacks
Losses on Wall Street and falling bond yields weighed on global markets this week. Investors in Europe continued to receive earnings reports and economic data. Asia’s stocks languished in the red for most of the week with the Nikkei 225 suffering a six-day losing stretch. Bank stocks and strong U.S. jobs data weighed on Brazil’s stocks over the week. (315-0)

Stocks To Watch: Welcome To The Party Rising Rates

2018-02-03 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. (945-5)

AstraZeneca Group plc 2017 Q4 - Results - Earnings Call Slides

2018-02-02 seekingalpha
The following slide deck was published by AstraZeneca Group plc in conjunction with their 2017 Q4 earnings call. (38-0)

ROTY Edition 1 Volume 75: The Future Of ROTY, Cascadian Acquired And Updates

2018-02-02 seekingalpha
I encourage readers to check out my recent blog post which goes into detail regarding changes to Seeking Alpha and consequently to ROTY. (539-1)